Cationic proteins and bronchial hyperresponsiveness.
Mark Madison
J
J
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Schramm
C M
CM
D000818:Animals; D001249:Asthma / Q000503:physiopathology*; D001798:Blood Proteins / Q000378:metabolism; D016535:Bronchial Hyperreactivity / Q000503:physiopathology*; D047091:Eosinophil Granule Proteins; D006801:Humans; D007249:Inflammation / Q000503:physiopathology; D051036:Large-Conductance Calcium-Activated Potassium Channels; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism; D026902:Potassium Channel Blockers; D015221:Potassium Channels / Q000378:metabolism; D024681:Potassium Channels, Calcium-Activated; D011506:Proteins / Q000378:metabolism*; D012260:Ribonucleases
D001798:Blood Proteins; D047091:Eosinophil Granule Proteins; D051036:Large-Conductance Calcium-Activated Potassium Channels; D026902:Potassium Channel Blockers; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; D011506:Proteins; D012260:Ribonucleases